nodes	percent_of_prediction	percent_of_DWPC	metapath
Bosentan—EDNRB—GPCR ligand binding—HTR2A—Parkinson's disease	0.00166	0.00166	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—ADORA2A—Parkinson's disease	0.00166	0.00166	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—PDYN—Parkinson's disease	0.00166	0.00166	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—PENK—Parkinson's disease	0.00164	0.00164	CbGpPWpGaD
Bosentan—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—Parkinson's disease	0.0016	0.0016	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—GRK5—Parkinson's disease	0.0016	0.0016	CbGpPWpGaD
Bosentan—EDNRB—GPCR downstream signaling—HTR1A—Parkinson's disease	0.00159	0.00159	CbGpPWpGaD
Bosentan—CYP2C9—Arachidonic acid metabolism—GPX1—Parkinson's disease	0.00158	0.00158	CbGpPWpGaD
Bosentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	0.00156	0.00156	CbGpPWpGaD
Bosentan—EDNRB—GPCR downstream signaling—TAC1—Parkinson's disease	0.00156	0.00156	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—GRM5—Parkinson's disease	0.00154	0.00154	CbGpPWpGaD
Bosentan—CYP3A4—Tryptophan metabolism—CYP2E1—Parkinson's disease	0.00153	0.00153	CbGpPWpGaD
Bosentan—EDNRB—GPCR downstream signaling—DRD1—Parkinson's disease	0.00153	0.00153	CbGpPWpGaD
Bosentan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—Parkinson's disease	0.00153	0.00153	CbGpPWpGaD
Bosentan—CYP2C9—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.00152	0.00152	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—GPR37—Parkinson's disease	0.00151	0.00151	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—DGKQ—Parkinson's disease	0.00151	0.00151	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—PDYN—Parkinson's disease	0.0015	0.0015	CbGpPWpGaD
Bosentan—EDNRB—GPCR downstream signaling—DRD3—Parkinson's disease	0.00148	0.00148	CbGpPWpGaD
Bosentan—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	0.00148	0.00148	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—HTR1A—Parkinson's disease	0.00144	0.00144	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—GRM4—Parkinson's disease	0.00143	0.00143	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—TAC1—Parkinson's disease	0.00142	0.00142	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—GRM5—Parkinson's disease	0.0014	0.0014	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—DRD1—Parkinson's disease	0.00139	0.00139	CbGpPWpGaD
Bosentan—EDNRB—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.00139	0.00139	CbGpPWpGaD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	0.00138	0.00138	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—PPP1R1B—Parkinson's disease	0.00138	0.00138	CbGpPWpGaD
Bosentan—EDNRA—GPCR ligand binding—EDN1—Parkinson's disease	0.00136	0.00136	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—MAG—Parkinson's disease	0.00136	0.00136	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—PENK—Parkinson's disease	0.00136	0.00136	CbGpPWpGaD
Bosentan—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—Parkinson's disease	0.00136	0.00136	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—DRD3—Parkinson's disease	0.00135	0.00135	CbGpPWpGaD
Bosentan—EDNRB—GPCR downstream signaling—HTR7—Parkinson's disease	0.00134	0.00134	CbGpPWpGaD
Bosentan—EDNRB—GPCR downstream signaling—DRD2—Parkinson's disease	0.00134	0.00134	CbGpPWpGaD
Bosentan—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—Parkinson's disease	0.00134	0.00134	CbGpPWpGaD
Bosentan—CYP2C9—Biological oxidations—GSTA4—Parkinson's disease	0.00134	0.00134	CbGpPWpGaD
Bosentan—CYP2C9—Metapathway biotransformation—GSTA4—Parkinson's disease	0.00132	0.00132	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.00131	0.00131	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—ND3—Parkinson's disease	0.0013	0.0013	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—MCCC1—Parkinson's disease	0.0013	0.0013	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—ADRBK1—Parkinson's disease	0.00126	0.00126	CbGpPWpGaD
Bosentan—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.00125	0.00125	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—PDYN—Parkinson's disease	0.00124	0.00124	CbGpPWpGaD
Bosentan—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.00124	0.00124	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—OMD—Parkinson's disease	0.00123	0.00123	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—TALDO1—Parkinson's disease	0.00123	0.00123	CbGpPWpGaD
Bosentan—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.00122	0.00122	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—HTR7—Parkinson's disease	0.00122	0.00122	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—DRD2—Parkinson's disease	0.00122	0.00122	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—RIT2—Parkinson's disease	0.00121	0.00121	CbGpPWpGaD
Bosentan—CYP2C9—Biological oxidations—MAOB—Parkinson's disease	0.00119	0.00119	CbGpPWpGaD
Bosentan—EDNRA—GPCR ligand binding—HTR2A—Parkinson's disease	0.00119	0.00119	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—ADORA2A—Parkinson's disease	0.00119	0.00119	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—GFAP—Parkinson's disease	0.00117	0.00117	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—NDUFB11—Parkinson's disease	0.00116	0.00116	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—GRM5—Parkinson's disease	0.00115	0.00115	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—GRK5—Parkinson's disease	0.00114	0.00114	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—HTR1A—Parkinson's disease	0.00114	0.00114	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—TAC1—Parkinson's disease	0.00112	0.00112	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—GCH1—Parkinson's disease	0.00111	0.00111	CbGpPWpGaD
Bosentan—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.0011	0.0011	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—DRD1—Parkinson's disease	0.0011	0.0011	CbGpPWpGaD
Bosentan—EDNRB—GPCR downstream signaling—EDN1—Parkinson's disease	0.00108	0.00108	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—DRD3—Parkinson's disease	0.00106	0.00106	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—HTR1A—Parkinson's disease	0.00103	0.00103	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—GRM4—Parkinson's disease	0.00102	0.00102	CbGpPWpGaD
Bosentan—EDNRB—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	0.00102	0.00102	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—TAC1—Parkinson's disease	0.00102	0.00102	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—FGF20—Parkinson's disease	0.00101	0.00101	CbGpPWpGaD
Bosentan—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.00101	0.00101	CbGpPWpGaD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	0.001	0.001	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—DRD1—Parkinson's disease	0.000996	0.000996	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.000992	0.000992	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—GBA—Parkinson's disease	0.000988	0.000988	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—FBP1—Parkinson's disease	0.000988	0.000988	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—DBH—Parkinson's disease	0.000988	0.000988	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—ADORA2A—Parkinson's disease	0.000981	0.000981	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—EDN1—Parkinson's disease	0.000976	0.000976	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—PENK—Parkinson's disease	0.000972	0.000972	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—MAG—Parkinson's disease	0.000972	0.000972	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—DRD3—Parkinson's disease	0.000965	0.000965	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—HTR7—Parkinson's disease	0.000961	0.000961	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—DRD2—Parkinson's disease	0.000961	0.000961	CbGpPWpGaD
Bosentan—EDNRB—GPCR downstream signaling—HTR2A—Parkinson's disease	0.00094	0.00094	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—INSR—Parkinson's disease	0.000906	0.000906	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—ADRBK1—Parkinson's disease	0.000901	0.000901	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—PDYN—Parkinson's disease	0.000889	0.000889	CbGpPWpGaD
Bosentan—CYP2C9—Biological oxidations—CYP2D6—Parkinson's disease	0.000886	0.000886	CbGpPWpGaD
Bosentan—CYP3A4—Biological oxidations—GSTA4—Parkinson's disease	0.000882	0.000882	CbGpPWpGaD
Bosentan—CYP2C9—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.000873	0.000873	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—DRD2—Parkinson's disease	0.000873	0.000873	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—HTR7—Parkinson's disease	0.000873	0.000873	CbGpPWpGaD
Bosentan—CYP3A4—Metapathway biotransformation—GSTA4—Parkinson's disease	0.00087	0.00087	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—FGB—Parkinson's disease	0.000856	0.000856	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—HTR2A—Parkinson's disease	0.000854	0.000854	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—HTR1A—Parkinson's disease	0.000852	0.000852	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—TAC1—Parkinson's disease	0.000839	0.000839	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—GFAP—Parkinson's disease	0.000835	0.000835	CbGpPWpGaD
Bosentan—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.000827	0.000827	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—GRM5—Parkinson's disease	0.000826	0.000826	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—DRD1—Parkinson's disease	0.000822	0.000822	CbGpPWpGaD
Bosentan—CYP2C9—Biological oxidations—CYP2E1—Parkinson's disease	0.00081	0.00081	CbGpPWpGaD
Bosentan—CYP2C9—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.000799	0.000799	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—DRD3—Parkinson's disease	0.000796	0.000796	CbGpPWpGaD
Bosentan—CYP3A4—Biological oxidations—MAOB—Parkinson's disease	0.000786	0.000786	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—EDN1—Parkinson's disease	0.000769	0.000769	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—ADRBK1—Parkinson's disease	0.000744	0.000744	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	0.000741	0.000741	CbGpPWpGaD
Bosentan—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	0.000733	0.000733	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—DDC—Parkinson's disease	0.000725	0.000725	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—FGF20—Parkinson's disease	0.000724	0.000724	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—DRD2—Parkinson's disease	0.00072	0.00072	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—HTR7—Parkinson's disease	0.00072	0.00072	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—ADORA2A—Parkinson's disease	0.000702	0.000702	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—EDN1—Parkinson's disease	0.000699	0.000699	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—GSTA4—Parkinson's disease	0.000685	0.000685	CbGpPWpGaD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	0.000676	0.000676	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000673	0.000673	CbGpPWpGaD
Bosentan—CYP2C9—Biological oxidations—COMT—Parkinson's disease	0.000671	0.000671	CbGpPWpGaD
Bosentan—CYP2C9—Biological oxidations—GSTP1—Parkinson's disease	0.000668	0.000668	CbGpPWpGaD
Bosentan—CYP2C9—Biological oxidations—MAOA—Parkinson's disease	0.000666	0.000666	CbGpPWpGaD
Bosentan—CYP2C9—Metapathway biotransformation—COMT—Parkinson's disease	0.000662	0.000662	CbGpPWpGaD
Bosentan—CYP2C9—Metapathway biotransformation—GSTP1—Parkinson's disease	0.000659	0.000659	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—INSR—Parkinson's disease	0.000648	0.000648	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—PLA2G6—Parkinson's disease	0.000617	0.000617	CbGpPWpGaD
Bosentan—CYP2C9—Biological oxidations—GSTM1—Parkinson's disease	0.000614	0.000614	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—FGB—Parkinson's disease	0.000613	0.000613	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—HTR2A—Parkinson's disease	0.000611	0.000611	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—MAOB—Parkinson's disease	0.00061	0.00061	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—HTR1A—Parkinson's disease	0.000609	0.000609	CbGpPWpGaD
Bosentan—CYP2C9—Metapathway biotransformation—GSTM1—Parkinson's disease	0.000605	0.000605	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—IGF2—Parkinson's disease	0.000604	0.000604	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—TAC1—Parkinson's disease	0.0006	0.0006	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—DRD1—Parkinson's disease	0.000589	0.000589	CbGpPWpGaD
Bosentan—CYP3A4—Biological oxidations—CYP2D6—Parkinson's disease	0.000584	0.000584	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—IGF1R—Parkinson's disease	0.000584	0.000584	CbGpPWpGaD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	0.000581	0.000581	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—EDN1—Parkinson's disease	0.000577	0.000577	CbGpPWpGaD
Bosentan—CYP3A4—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.000576	0.000576	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—DRD3—Parkinson's disease	0.00057	0.00057	CbGpPWpGaD
Bosentan—CYP3A4—Biological oxidations—CYP2E1—Parkinson's disease	0.000534	0.000534	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—ADRBK1—Parkinson's disease	0.000532	0.000532	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—NGF—Parkinson's disease	0.00053	0.00053	CbGpPWpGaD
Bosentan—CYP3A4—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.000527	0.000527	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—DRD2—Parkinson's disease	0.000516	0.000516	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—HTR7—Parkinson's disease	0.000516	0.000516	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—HTR2A—Parkinson's disease	0.000504	0.000504	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—APOE—Parkinson's disease	0.000469	0.000469	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	0.000462	0.000462	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—CYP2D6—Parkinson's disease	0.000454	0.000454	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—CTGF—Parkinson's disease	0.000445	0.000445	CbGpPWpGaD
Bosentan—CYP3A4—Biological oxidations—COMT—Parkinson's disease	0.000443	0.000443	CbGpPWpGaD
Bosentan—CYP3A4—Biological oxidations—GSTP1—Parkinson's disease	0.000441	0.000441	CbGpPWpGaD
Bosentan—CYP3A4—Biological oxidations—MAOA—Parkinson's disease	0.000439	0.000439	CbGpPWpGaD
Bosentan—CYP3A4—Metapathway biotransformation—COMT—Parkinson's disease	0.000437	0.000437	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—MCCC1—Parkinson's disease	0.000435	0.000435	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—ND3—Parkinson's disease	0.000435	0.000435	CbGpPWpGaD
Bosentan—CYP3A4—Metapathway biotransformation—GSTP1—Parkinson's disease	0.000434	0.000434	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—IGF2—Parkinson's disease	0.000432	0.000432	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—IGF1R—Parkinson's disease	0.000418	0.000418	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—CYP2E1—Parkinson's disease	0.000415	0.000415	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—EDN1—Parkinson's disease	0.000413	0.000413	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—NQO1—Parkinson's disease	0.00041	0.00041	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—TALDO1—Parkinson's disease	0.000409	0.000409	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—OMD—Parkinson's disease	0.000409	0.000409	CbGpPWpGaD
Bosentan—CYP3A4—Biological oxidations—GSTM1—Parkinson's disease	0.000405	0.000405	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—TH—Parkinson's disease	0.000404	0.000404	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—INS—Parkinson's disease	0.000401	0.000401	CbGpPWpGaD
Bosentan—CYP3A4—Metapathway biotransformation—GSTM1—Parkinson's disease	0.000399	0.000399	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—CYCS—Parkinson's disease	0.000388	0.000388	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—NDUFB11—Parkinson's disease	0.000388	0.000388	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—NGF—Parkinson's disease	0.000379	0.000379	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—GCH1—Parkinson's disease	0.00037	0.00037	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—HTR2A—Parkinson's disease	0.000361	0.000361	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—COMT—Parkinson's disease	0.000344	0.000344	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—GSTP1—Parkinson's disease	0.000342	0.000342	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—MAOA—Parkinson's disease	0.000341	0.000341	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—HMOX1—Parkinson's disease	0.000337	0.000337	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—APOE—Parkinson's disease	0.000336	0.000336	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	0.000334	0.000334	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—GBA—Parkinson's disease	0.00033	0.00033	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—DBH—Parkinson's disease	0.00033	0.00033	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—FBP1—Parkinson's disease	0.00033	0.00033	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—ABCB1—Parkinson's disease	0.000324	0.000324	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—GSTM1—Parkinson's disease	0.000314	0.000314	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—GPX1—Parkinson's disease	0.000301	0.000301	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—CASP3—Parkinson's disease	0.000298	0.000298	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—IL6—Parkinson's disease	0.000296	0.000296	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—ND3—Parkinson's disease	0.000287	0.000287	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—MCCC1—Parkinson's disease	0.000287	0.000287	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—INS—Parkinson's disease	0.000287	0.000287	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—MTHFR—Parkinson's disease	0.000278	0.000278	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—MAPK8—Parkinson's disease	0.000274	0.000274	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—TALDO1—Parkinson's disease	0.00027	0.00027	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—OMD—Parkinson's disease	0.00027	0.00027	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—APOE—Parkinson's disease	0.000259	0.000259	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	0.000256	0.000256	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—GCH1—Parkinson's disease	0.000244	0.000244	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—DDC—Parkinson's disease	0.000242	0.000242	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—GSTA4—Parkinson's disease	0.000229	0.000229	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	0.000226	0.000226	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—INS—Parkinson's disease	0.000221	0.000221	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—FBP1—Parkinson's disease	0.000218	0.000218	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—DBH—Parkinson's disease	0.000218	0.000218	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—GBA—Parkinson's disease	0.000218	0.000218	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CASP3—Parkinson's disease	0.000214	0.000214	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—IL6—Parkinson's disease	0.000212	0.000212	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—PLA2G6—Parkinson's disease	0.000206	0.000206	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—MAOB—Parkinson's disease	0.000204	0.000204	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—MAPK8—Parkinson's disease	0.000196	0.000196	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	0.000194	0.000194	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—IL6—Parkinson's disease	0.000175	0.000175	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—DDC—Parkinson's disease	0.00016	0.00016	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—CYP2D6—Parkinson's disease	0.000151	0.000151	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—GSTA4—Parkinson's disease	0.000151	0.000151	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—CTGF—Parkinson's disease	0.000149	0.000149	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—CYP2E1—Parkinson's disease	0.000139	0.000139	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—NQO1—Parkinson's disease	0.000137	0.000137	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	0.000136	0.000136	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—TH—Parkinson's disease	0.000135	0.000135	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—MAOB—Parkinson's disease	0.000134	0.000134	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—CYCS—Parkinson's disease	0.00013	0.00013	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—IL6—Parkinson's disease	0.000125	0.000125	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—COMT—Parkinson's disease	0.000115	0.000115	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—GSTP1—Parkinson's disease	0.000114	0.000114	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—MAOA—Parkinson's disease	0.000114	0.000114	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—HMOX1—Parkinson's disease	0.000113	0.000113	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—ABCB1—Parkinson's disease	0.000108	0.000108	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—GSTM1—Parkinson's disease	0.000105	0.000105	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—GPX1—Parkinson's disease	0.000101	0.000101	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	9.99e-05	9.99e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—CTGF—Parkinson's disease	9.8e-05	9.8e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—MTHFR—Parkinson's disease	9.28e-05	9.28e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	9.13e-05	9.13e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—NQO1—Parkinson's disease	9.03e-05	9.03e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—TH—Parkinson's disease	8.9e-05	8.9e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—APOE—Parkinson's disease	8.64e-05	8.64e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—CYCS—Parkinson's disease	8.55e-05	8.55e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—COMT—Parkinson's disease	7.57e-05	7.57e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—GSTP1—Parkinson's disease	7.53e-05	7.53e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—MAOA—Parkinson's disease	7.52e-05	7.52e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—HMOX1—Parkinson's disease	7.43e-05	7.43e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—INS—Parkinson's disease	7.38e-05	7.38e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—ABCB1—Parkinson's disease	7.13e-05	7.13e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—GSTM1—Parkinson's disease	6.92e-05	6.92e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—GPX1—Parkinson's disease	6.63e-05	6.63e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—MTHFR—Parkinson's disease	6.12e-05	6.12e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—APOE—Parkinson's disease	5.7e-05	5.7e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—INS—Parkinson's disease	4.87e-05	4.87e-05	CbGpPWpGaD
